Synergetics USA, Inc. (NASDAQ:SURG)

CAPS Rating: 2 out of 5

The Company designs, manufactures and markets precision-engineered, microsurgical instruments, capital equipment and devices primarily for use in vitreoretinal surgery and neurosurgical applications.

Recs

0
Player Avatar EnigmaDude (98.21) Submitted: 9/20/2012 1:41:41 PM : Outperform Start Price: $5.23 SURG Score: -40.90

Profitable with 20% projected growth and no debt. Pop today on analyst upgrade, should keep going up.

Featured Broker Partners


Advertisement